Gene · 4043
Papers2,811
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,811
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Spherical nucleic acids-based nanoplatforms for tumor precision medicine and immunotherapy. | Mater Today Bio | 2023 | 37545568 | PubTator, text mining | PubMed |
| Receptor-associated protein impairs ligand binding to megalin and megalin-dependent endocytic flux in proximal tubule cells. | Am J Physiol Renal Physiol | 2023 | 37534387 | PubTator, text mining | PubMed |
| Hydroxychloroquine in nephrology: current status and future directions. | J Nephrol | 2023 | 37530940 | PubTator, text mining | PubMed |
| Metaviromic Characterization of Betaflexivirus Populations Associated with a Vitis cultivar Collection in South Africa. | Viruses | 2023 | 37515161 | PubTator, text mining | PubMed |
| Cell-Penetrating and Targeted Peptides Delivery Systems as Potential Pharmaceutical Carriers for Enhanced Delivery across the Blood-Brain Barrier (BBB). | Pharmaceutics | 2023 | 37514185 | PubTator, text mining | PubMed |
| Thymocyte Development of Humanized Mice Is Promoted by Interactions with Human-Derived Antigen Presenting Cells upon Immunization. | Int J Mol Sci | 2023 | 37511462 | PubTator, text mining | PubMed |
| DNA Methylation Signatures of Response to Conventional Synthetic and Biologic Disease-Modifying Antirheumatic Drugs (DMARDs) in Rheumatoid Arthritis. | Biomedicines | 2023 | 37509625 | PubTator, text mining | PubMed |
| Macrocyclic Peptidomimetic Plasmepsin X Inhibitors with Potent In Vitro and In Vivo Antimalarial Activity. | J Med Chem | 2023 | 37505188 | PubTator, text mining | PubMed |
| Lrp1 is essential for lethal Rift Valley fever hepatic disease in mice. | Sci Adv | 2023 | 37450601 | PubTator, text mining | PubMed |
| Inflammation of Dry Eye Syndrome: A Cellular Study of the Epithelial and Macrophagic Involvement of NFAT5 and RAGE. | Int J Mol Sci | 2023 | 37446230 | PubTator, text mining | PubMed |
| Potent New Targets for Autophagy Enhancement to Delay Neuronal Ageing. | Cells | 2023 | 37443788 | PubTator, text mining | PubMed |
| Membranes prime the RapGEF EPAC1 to transduce cAMP signaling. | Nat Commun | 2023 | 37438343 | PubTator, text mining | PubMed |
| Diagnosis of chronic pancreatitis using semi-quantitative MRI features of the pancreatic parenchyma: results from the multi-institutional MINIMAP study. | Abdom Radiol (NY) | 2023 | 37436452 | PubTator, text mining | PubMed |
| KLF4 targets RAB26 and decreases 5-FU resistance through inhibiting autophagy in colon cancer. | Cancer Biol Ther | 2023 | 37431852 | PubTator, text mining | PubMed |
| How Nanotherapeutic Platforms Play a Key Role in Glioma? A Comprehensive Review of Literature. | Int J Nanomedicine | 2023 | 37427368 | PubTator, text mining | PubMed |
| The old second messenger cAMP teams up with novel cell death mechanisms: potential translational therapeutical benefit for Alzheimer's disease and Parkinson's disease. | Front Physiol | 2023 | 37405135 | PubTator, text mining | PubMed |
| Umbilical cord mesenchymal stem cell-derived exosomes promote axon regeneration during optic nerve injury through microRNA-dependent mTORC1 signalling. | Clin Transl Med | 2023 | 37400961 | PubTator, text mining | PubMed |
| SerpinB3 Upregulates Low-Density Lipoprotein Receptor-Related Protein (LRP) Family Members, Leading to Wnt Signaling Activation and Increased Cell Survival and Invasiveness. | Biology (Basel) | 2023 | 37372056 | PubTator, text mining | PubMed |
| Activation Mechanisms and Diverse Functions of Mammalian Phospholipase C. | Biomolecules | 2023 | 37371495 | PubTator, text mining | PubMed |
| Automatic generation of creative text in Portuguese: an overview. | Lang Resour Eval | 2023 | 37360260 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4043/papers?page=13